Identifying the next generation of public life sciences leaders

A physician, investor and capital markets leader who helped build Metsera into one of biotech's fastest value-creation stories. His experience spans Chardan, UBS, Goldman Sachs and AllianceBernstein, along with executive roles across prior life sciences SPACs.

Washington University, MD · Chicago Booth, MBA · CFA Charterholder

Former General Partner at Acorn BioVentures and New Leaf Venture Partners, with prior experience at AllianceBernstein, Deutsche Bank and Health Advances. He has served as a director of multiple biotechnology companies.

MIT, PhD

Co-Founder, Managing Partner and President of Chardan, a healthcare-focused investment bank. He has led a platform that has completed or advised on 175 SPAC IPOs and de-SPAC transactions.

Founder, executive and director of 15 SPACs

Managing Director and Head of Biotech Private Equity at Ally Bridge Group, with prior experience at Jefferies, BMO Capital Markets and Canaccord Genuity, and extensive biotechnology board experience.

Long Island University, PharmD · Drexel University, MBA

A corporate finance and capital markets executive with more than 25 years of experience across strategic transactions and SPACs. He is a Managing Director at Chardan and an advisor to public and private growth companies.

Cornell University, BA · NYU Stern, MBA